A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

PHASE2CompletedINTERVENTIONAL
Enrollment

1,019

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

December 28, 2023

Study Completion Date

December 28, 2023

Conditions
Influenza, HumanCOVID-19
Interventions
BIOLOGICAL

bivalent BNT162b2 (original/Omi BA.4/BA.5)

Intramuscular injection

BIOLOGICAL

qIRV (22/23)

Intramuscular injection

BIOLOGICAL

QIV

Intramuscular injection

BIOLOGICAL

bIRV

Intramuscular injection

BIOLOGICAL

tIRV

Intramuscular injection

Trial Locations (59)

13215

SUNY Upstate Medical University Institute for Global Health, Syracuse

20904

Jadestone Clinical Research, Silver Spring

22911

Charlottesville Medical Research, Charlottesville

27612

M3 Wake Research, Inc., Raleigh

28112

Monroe Biomedical Research, Monroe

29566

Main Street Physician's Care, Little River

McLeod Cardiology Associates - Little River, Little River

30281

Clinical Research Atlanta, Stockbridge

31406

Velocity Clinical Research, Savannah, Savannah

31419

Savannah Medical Group, Savannah

32127

United Medical Research, Port Orange

33012

Indago Research & Health Center, Inc, Hialeah

33014

Palm Springs Community Health Center, Miami Lakes

Panax Clinical Research, Miami Lakes

33016

Palm Springs Community Health Center, Miami Lakes

33024

Research Centers of America ( Hollywood ), Hollywood

33029

DBC Research USA, Pembroke Pines

33122

Angels Clinical Research Institute, Miami

33155

Miami Clinical Research, Miami

33156

Gerardo Polanco, MD, Miami

33157

Innovation Medical Research Center, Palmetto Bay

33173

Research Institute of South Florida, Miami

33176

Entrust Clinical Research, Miami

Jackson Medical Group Cardiac Care, Miami

Miami Dade Medical Research Institute, LLC, Miami

33308

Proactive Clinical Research,LLC, Fort Lauderdale

33467

Finlay Medical Research, Greenacres City

35611

North Alabama Research Center, Athens

The Heart Center, Athens

37909

Alliance for Multispecialty Research, LLC, Knoxville

37920

Alliance for Multispecialty Research, LLC, Knoxville

43213

Centricity Research Columbus Ohio Multispecialty, Columbus

45212

CTI Clinical Research Center, Cincinnati

48334

Michigan Center of Medical Research (MICHMER), Farmington Hills

60126

Retina Associates, Elmhurst

60523

Affinity Health, Oak Brook

Alliance for Multispecialty Research, LLC, Oak Brook

60640

Great Lakes Clinical Trials - Ravenswood, Chicago

63005

Clinical Research Professionals, Chesterfield

63044

Pradeep Chandra, DO, FACC, Bridgeton

63141

Sundance Clinical Research, St Louis

67207

Alliance for Multispecialty Research, LLC, Wichita

68114

Quality Clinical Research, Omaha

68134

Velocity Clinical Research, Omaha, Omaha

68506

Pioneer Heart Institute, Lincoln

73112

Lynn Health Science Institute, Oklahoma City

77054

Prolato Clinical Research Center, Houston

77375

DM Clinical Research, Martin Diagnostic Clinic, Tomball

DM Clinical Research, Tomball

77555

University of Texas Medical Branch, Galveston

85018

HOPE Research Institute, Phoenix

The Pain Center of Arizona, Phoenix

92123

California Research Foundation, San Diego

92630

Orange County Research Center, Lake Forest

92780

Orange County Research Center, Tustin

92868

Orange County Heart Institute, Orange

96814

East-West Medical Research Institute, Honolulu

03801

ActivMed Practices & Research, LLC., Portsmouth

02818

Velocity Clinical Research, Providence, East Greenwich

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

BioNTech SE

INDUSTRY

NCT05596734 - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza | Biotech Hunter | Biotech Hunter